CHM chimeric therapeutics limited

rights issue

  1. 709 Posts.
    The announced fully underwritten rights issue indicates that some parties are keen to see CHM have its day in court. While it will dilute current share holdings, the price of the new offering (4c/share) even with the attached free option (exercisable at 2.5c) demands a slight premium over the recent trading price.

    This issue WILL raise $2.29M and another $1.43M should the attached options be converted. If current shareholders aren't keen to take up their entitlement so be it.

    Tomorrow is the day scheduled for the next direction hearing, hopefully we may get a trial date set for this matter. If so rights issue may be the only place we will be able to get a share for 4c.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $9.068M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $1.51K 350K

Buyers (Bids)

No. Vol. Price($)
26 15432293 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 17499687 19
View Market Depth
Last trade - 12.28pm 03/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.